申请人:Akolkar Nakul Pramod
公开号:US20120040897A1
公开(公告)日:2012-02-16
A compound of formula (I) or a tautomeric form, regioisomer, stereoisomer, solvate, N-oxide or pharmaceutically acceptable salts thereof; wherein ‘a’—is selected from the group consisting of substituted or unsubstituted heterocycloalkyl ring and substituted or unsubstituted carbohydrate moiety y is a member selected from —O—, —CO—, —S02-, aminoalkyl or formula (II) wherein, R
w
is hydrogen, substituted or unsubstituted alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl; x is a member selected from -0-, —S—, —SO—, —S02-, CONR10, NR10CO and —NR
d
—, or x and y together represent a chemical bond; Z is selected from —CH—, —N—. t is an integer selected from O to 4; with the provisos that when ‘a’ is substituted or unsubstituted heterocycloalkyl ring then ‘t’ is not O and when y=—CO—, x is not NR
d
.
化合物的公式(I)或其互变异构体,区域异构体,立体异构体,溶剂化物,N-氧化物或其药学上可接受的盐;其中,‘a’选择自取代或未取代的杂环烷基环或取代或未取代的碳水化合物基团,y为成员选择自—O—,—CO—,—S02-,氨基烷基或公式(II)其中,Rw为氢,取代或未取代的烷基,烯基,炔基,环烷基,芳基,杂环芳基;x为成员选择自-0-,—S—,—SO—,—S02-,CONR10,NR10CO和—NRd—,或x和y一起表示化学键;Z选择自—CH—,—N—。 t为整数,选择自0到4;条件是当‘a’为取代或未取代的杂环烷基环时,‘t’不为0,当y=—CO—时,x不为NRd。